(11.BETA.,16.BETA.)-9-FLUORO-11-HYDROXY-16-METHYL-21-((METHYLSULFONYL)OXY)-17-(1-OXOPROPOXY)PREGNA-1,4-DIENE-3,20-DIONE
UNII GA4A80ZP11
Substance Identification & Data
This profile provides standardized clinical and technical data for (11.beta.,16.beta.)-9-fluoro-11-hydroxy-16-methyl-21-((methylsulfonyl)oxy)-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GA4A80ZP11.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 15423-80-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H35FO8S LJIXIWVFIFXMTE-SOMXGXJRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (11.beta.,16.beta.)-9-fluoro-11-hydroxy-16-methyl-21-((methylsulfonyl)oxy)-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.